
Work Here?
Delfa provides an AI-native operating system to automate clinical trial operations, starting with patient recruitment. Its platform uses multilingual AI agents to outreach via phone, SMS, and chat to pre-screen eligibility, answer questions, schedule visits, and send reminders, while centralizing communications and data and syncing with CTMS. Delfa differentiates itself through end-to-end automation, multilingual agents, and tight CTMS integration, serving clinical research site networks with real-world case results. Its goal is to become a full-stack operating system for clinical trials that enables smarter site selection and automated study start-up to reduce enrollment delays.
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$3.8M
Headquarters
San Francisco, California
Founded
2024
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$3.8M
Above
Industry Average
Funded Over
1 Rounds
Industry standards
Health Insurance
Gym Membership
Paid Holidays
Company Equity
London-based startup Delfa, which accelerates patient enrollment in clinical trials using voice AI, has raised $3.8 million from Air Street Capital. Delfa automates patient outreach, screening, and enrollment, saving recruiters up to 20 hours per week and speeding up trials. The funding will help build a CRM for patient recruitment. Delfa currently supports over 50 trials, mainly in the U.S., and aims to work directly with pharma companies to standardize and improve trial management.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$3.8M
Headquarters
San Francisco, California
Founded
2024
Find jobs on Simplify and start your career today